Jeff Aronin and Paragon Biosciences: Working to Help Patients

One of the great challenges in biotech and pharma today is getting medicines approved. While many ideas come from laboratories around the world, the failure rate is still very high at a time where the need for breakthrough medicines has never been greater. That is the challenge that Paragon Biosciences, and its leader Jeff Aronin, strive to meet every day.

Paragon is a Chicago-based incubator and investor that builds and grows leading biotechnology companies (Alivenewspaper). It uniquely focuses on patient need, the science behind the disease and building great companies to quickly bring novel treatments to patients. Aronin and Paragon have an outstanding track record in what matters most: getting medicines approved, with some 13 new drugs approved, on par with most Big Pharma companies over the past decade.

Paragon always starts with the patient need. When it identifies a debilitating disease with no effective treatment, Aronin and his team move forward quickly to address that need. It is not enough to just realize there may be an opportunity in a certain disease state. What drives the team is the desire to understand what causes a disease, what treatment can help and how can Paragon best bring a treatment to patients.

Paragon Biosciences was created with a straightforward, but important, goal: to build innovative companies that bring important medicines to patients. Paragon’s portfolio companies are managed by healthcare industry leaders and biotech entrepreneurs committed to delivering better health outcomes for patients with diseases that go largely untreated today. With more than 6,000 diseases today that do not have an approved therapy available, the work that Paragon Biosciences, Jeff Aronin, and his team will do has never been more needed or important.

Paragon’s strategy is straightforward: First, learn the disease. Second, understand the science. Third, remove all guesswork. The result is a rational pathway for approval for a medicine that addresses an unmet need.

Jeff Aronin’s strategy and Paragon’s development model are exactly what healthcare needs today: an efficient, focused strategy that puts patients first and addresses true unmet medical needs.